966 related articles for article (PubMed ID: 11485986)
21. Fetal human hematopoietic stem cells can differentiate sequentially into neural stem cells and then astrocytes in vitro.
Hao HN; Zhao J; Thomas RL; Parker GC; Lyman WD
J Hematother Stem Cell Res; 2003 Feb; 12(1):23-32. PubMed ID: 12662433
[TBL] [Abstract][Full Text] [Related]
22. Expression of non-glial intermediate filament proteins in gliomas.
Hirato J; Nakazato Y; Ogawa A
Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
[TBL] [Abstract][Full Text] [Related]
23. Sorbitol causes preferential selection of Muller glial precursors from late retinal progenitor cells in vitro.
Zahir T; Klassen H; Tomita M; Young MJ
Mol Vis; 2006 Dec; 12():1606-14. PubMed ID: 17200660
[TBL] [Abstract][Full Text] [Related]
24. GFAP-deficient astrocytes are capable of stellation in vitro when cocultured with neurons and exhibit a reduced amount of intermediate filaments and an increased cell saturation density.
Pekny M; Eliasson C; Chien CL; Kindblom LG; Liem R; Hamberger A; Betsholtz C
Exp Cell Res; 1998 Mar; 239(2):332-43. PubMed ID: 9521851
[TBL] [Abstract][Full Text] [Related]
25. A mouse model for glioma: biology, pathology, and therapeutic opportunities.
Holland EC
Toxicol Pathol; 2000; 28(1):171-7. PubMed ID: 10669005
[TBL] [Abstract][Full Text] [Related]
26. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops.
Hermanson M; Funa K; Hartman M; Claesson-Welsh L; Heldin CH; Westermark B; Nistér M
Cancer Res; 1992 Jun; 52(11):3213-9. PubMed ID: 1317261
[TBL] [Abstract][Full Text] [Related]
27. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells.
Bögler O; Wren D; Barnett SC; Land H; Noble M
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6368-72. PubMed ID: 2201028
[TBL] [Abstract][Full Text] [Related]
28. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
[TBL] [Abstract][Full Text] [Related]
29. Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model.
Hesselager G; Uhrbom L; Westermark B; Nistér M
Cancer Res; 2003 Aug; 63(15):4305-9. PubMed ID: 12907595
[TBL] [Abstract][Full Text] [Related]
30. In vitro identification and functional characterization of glial precursor cells in human gliomas.
Colin C; Baeza N; Tong S; Bouvier C; Quilichini B; Durbec P; Figarella-Branger D
Neuropathol Appl Neurobiol; 2006 Apr; 32(2):189-202. PubMed ID: 16599947
[TBL] [Abstract][Full Text] [Related]
31. Measurement of time in oligodendrocyte-type-2 astrocyte (O-2A) progenitors is a cellular process distinct from differentiation or division.
Bögler O; Noble M
Dev Biol; 1994 Apr; 162(2):525-38. PubMed ID: 8150211
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas.
Calatozzolo C; Maderna E; Pollo B; Gelati M; Marras C; Silvani A; Croci D; Boiardi A; Salmaggi A
Cancer Biol Ther; 2006 Jul; 5(7):827-32. PubMed ID: 16760646
[TBL] [Abstract][Full Text] [Related]
33. Developmental and post-injury cortical gliogenesis: a genetic fate-mapping study with Nestin-CreER mice.
Burns KA; Murphy B; Danzer SC; Kuan CY
Glia; 2009 Aug; 57(10):1115-29. PubMed ID: 19115384
[TBL] [Abstract][Full Text] [Related]
34. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
Gupta M; Djalilvand A; Brat DJ
Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
[TBL] [Abstract][Full Text] [Related]
35. Nestin-positive mesenchymal stem cells favour the astroglial lineage in neural progenitors and stem cells by releasing active BMP4.
Wislet-Gendebien S; Bruyère F; Hans G; Leprince P; Moonen G; Rogister B
BMC Neurosci; 2004 Sep; 5():33. PubMed ID: 15369599
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis.
Shih AH; Dai C; Hu X; Rosenblum MK; Koutcher JA; Holland EC
Cancer Res; 2004 Jul; 64(14):4783-9. PubMed ID: 15256447
[TBL] [Abstract][Full Text] [Related]
37. Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance.
Maxwell M; Naber SP; Wolfe HJ; Galanopoulos T; Hedley-Whyte ET; Black PM; Antoniades HN
J Clin Invest; 1990 Jul; 86(1):131-40. PubMed ID: 2164040
[TBL] [Abstract][Full Text] [Related]
38. Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural grafting or brain wounds.
Krum JM; Rosenstein JM
Exp Neurol; 1999 Dec; 160(2):348-60. PubMed ID: 10619552
[TBL] [Abstract][Full Text] [Related]
39. Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.
Huang ZY; Baldwin RL; Hedrick NM; Gutmann DH
Oncogene; 2002 Feb; 21(9):1325-34. PubMed ID: 11857076
[TBL] [Abstract][Full Text] [Related]
40. Platelet-derived growth factor in human glioma.
Westermark B; Heldin CH; Nistér M
Glia; 1995 Nov; 15(3):257-63. PubMed ID: 8586462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
